Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin heavy variable (III)-25-1, abbreviated as IGHVIII-25-1, is a pseudogene in the variable region gene cluster of the human immunoglobulin heavy chain locus. Pseudogenes are genes that resemble known genes but are non-functional due to mutations, truncations, or other sequence disruptions that prevent protein expression. IGHVIII-25-1 does not contribute to the functional diversity of immunoglobulin molecules and is not involved in immune system function, disease mechanisms, or therapeutic targeting. Functional IGHV gene segments undergo somatic recombination to form the variable region of antibody heavy chains, critical for antigen recognition, but pseudogenes like IGHVIII-25-1 are silent and do not participate in these processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy variable (III)-25-1 pseudogene (IGHVIII-25-1).